Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Maxcyte (MXCT) EBT Margin (2020 - 2025)

Maxcyte (MXCT) has disclosed EBT Margin for 6 consecutive years, with 201.22% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 32312.0% to 201.22% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 212.96% through Dec 2025, down 8806.0% year-over-year, with the annual reading at 212.96% for FY2025, 10667.0% down from the prior year.
  • EBT Margin for Q4 2025 was 201.22% at Maxcyte, up from 181.81% in the prior quarter.
  • The five-year high for EBT Margin was 201.22% in Q4 2025, with the low at 428.75% in Q4 2021.
  • Average EBT Margin over 5 years is 100.41%, with a median of 117.27% recorded in 2023.
  • The sharpest move saw EBT Margin tumbled -54391bps in 2021, then surged 40808bps in 2022.
  • Over 5 years, EBT Margin stood at 428.75% in 2021, then soared by 95bps to 20.67% in 2022, then skyrocketed by 517bps to 86.16% in 2023, then crashed by -241bps to 121.9% in 2024, then soared by 265bps to 201.22% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 201.22%, 181.81%, and 145.26% for Q4 2025, Q3 2025, and Q2 2025 respectively.